Karin Schön

Class-switch recombination to IgA in the Peyer's patches requires natural thymus-derived Tregs and appears to be antigen independent.
Inta Gribonika, Dubravka Grdic Eliasson, Rakesh Chandode, Karin Schön, Anneli Strömberg et al.
Mucosal immunology, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection.
Dubravka Grdic Eliasson, Ajibola Omokanye, Karin Schön, Ulf Alexander Wenzel, Valentina Bernasconi et al.
Mucosal immunology, Artikel i vetenskaplig tidskrift 2018
Artikel i vetenskaplig tidskrift

Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections
Valentina Bernasconi, B. Bernocchi, L. Ye, M. Q. Le, Ajibola Omokanye et al.
Frontiers in Immunology, Artikel i vetenskaplig tidskrift 2018
Artikel i vetenskaplig tidskrift

A Novel Approach to Reinstating Tolerance in Experimental Autoimmune Myasthenia Gravis Using Targeted Fusion Protein, mCTA1-T146
A. Consonni, Sapna Sharma, Karin Schön, C. Lebrero-Fernandez, E. Rinaldi et al.
Frontiers in Immunology, Artikel i vetenskaplig tidskrift 2017
Artikel i vetenskaplig tidskrift

A Sensitive Method for Detecting Peptide-specific CD4(+) T Cell Responses in Peripheral Blood from Patients with Myasthenia Gravis
Sapna Sharma, C. Malmestrom, Sarah Meisel, Karin Schön, M. Verolin et al.
Frontiers in Immunology, Artikel i vetenskaplig tidskrift 2017
Artikel i vetenskaplig tidskrift

Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen
R. Hadad, Ellen Marks, I. Kalbina, Karin Schön, M. Unemo et al.
Acta Pathologica, Microbiologica et Immunologica Scandinavica, Artikel i vetenskaplig tidskrift 2016
Artikel i vetenskaplig tidskrift

Feeding transgenic plants that express a tolerogenic fusion protein effectively protects against arthritis.
Charlotta Hansson, Karin Schön, Irina Kalbina, Åke Strid, Sören Andersson et al.
Plant biotechnology journal, Artikel i vetenskaplig tidskrift 2016
Artikel i vetenskaplig tidskrift

Cholera toxin adjuvant promotes a balanced Th1/Th2/Th17 response independently of IL-12 and IL-17 by acting on Gsα in CD11b(+) DCs.
Johan Mattsson, Karin Schön, Lena Ekman, Linda Fahlén-Yrlid, Ulf Yrlid et al.
Mucosal immunology, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

Subcomponent Vaccine Based on CTA1-DD Adjuvant with Incorporated UreB Class II Peptides Stimulates Protective Helicobacter pylori Immunity
J. G. Nedrud, N. Bagheri, Karin Schön, W. Xin, Hilda Bergroth et al.
Plos One, Artikel i vetenskaplig tidskrift 2013
Artikel i vetenskaplig tidskrift

CD4(+) T-cell immunity in the female genital tract is critically dependent on local mucosal immunization.
Ellen Marks, Anja Helgeby, Jan O Andersson, Karin Schön, Nils Y Lycke
European journal of immunology, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.
Johan Mattsson, Ulf Yrlid, Anneli Stensson, Karin Schön, Mikael C I Karlsson et al.
Journal of immunology (Baltimore, Md. : 1950), Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus.
Dubravka Grdic Eliasson, Anja Helgeby, Karin Schön, Caroline Nygren, Karim El-Bakkouri et al.
Vaccine, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

Gene expression profiling identifies STAT3 as a novel pathway for immunomodulation by cholera toxin adjuvant.
A Sjöblom-Hallén, Annika Nerstedt, Karin Schön, Lena Ekman, Peter Bergqvist et al.
Mucosal immunology, Artikel i vetenskaplig tidskrift 2010
Artikel i vetenskaplig tidskrift

ADP-ribosylation control the outcome of tolerance or enhanced priming following mucosal immunization.
Annemarie Hasselberg, Lena Ekman, Linda Fahlén-Yrlid, Karin Schön, Nils Y Lycke
Journal of Immunology, Artikel i vetenskaplig tidskrift 2010
Artikel i vetenskaplig tidskrift

Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis.
Annemarie Hasselberg, Karin Schön, Andrej Tarkowski, Nils Y Lycke
Arthritis and rheumatism, Artikel i vetenskaplig tidskrift 2009
Artikel i vetenskaplig tidskrift

CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization.
Christopher Sundling, Karin Schön, Andreas Mörner, Mattias N E Forsell, Richard T Wyatt et al.
The Journal of general virology, Artikel i vetenskaplig tidskrift 2008
Artikel i vetenskaplig tidskrift

CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.
Dubravka Grdic Eliasson, Karim El Bakkouri, Karin Schön, Anna Ramne, Els Festjens et al.
Vaccine, Artikel i vetenskaplig tidskrift 2008
Artikel i vetenskaplig tidskrift

The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
Aliasghar Akhiani, Anneli Stensson, Karin Schön, Nils Y Lycke
Scandinavian journal of immunology, Artikel i vetenskaplig tidskrift 2006
Artikel i vetenskaplig tidskrift

The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells.
Anja Helgeby, Neil C Robson, Anne M Donachie, Helen Beackock-Sharp, Karin Lövgren et al.
Journal of immunology (Baltimore, Md. : 1950), Forskningsöversiktsartikel 2006
Forskningsöversiktsartikel

IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice.
Aliasghar Akhiani, Anneli Stensson, Karin Schön, Nils Y Lycke
Journal of immunology (Baltimore, Md. : 1950), Artikel i vetenskaplig tidskrift 2005
Artikel i vetenskaplig tidskrift